Vaccines

SEC Loosens Revenue-Recognition Rules for Vaccine Stockpile Participants

NIAID Boosts Vaccine Innovation but Draws Controversy

Adjuvant for HPV Vaccine Enhances Immune Response Levels

Chiron Looks to Flu Vaccine Cell Culture; FDA Gears Up

Collaboration Targets Single-Shot Japanese Encephalitis Vaccine

Genecor Wins Vaccine-Development Contract

FDA Calls Chiron Facility Acceptable; GSK Gets Green Light For Flu Vaccine

Bavarian Nordic Sues Acambis for Patent Infringement

Acambis and Bavarian Nordic Vie for Smallpox Vaccine Contract

GSK Releases Flu Vaccine Production Strategies

US Government Orders 2M Doses of Avian Flu Vaccine

Chiron Cuts Supply of Flu Vaccines Made in Germany; Liverpool Plant Under Inspection

Vaccine developers are using novel drug delivery methods that offer advantages over traditional techniques such as improved immunogenicity, better stability, specific control over antigen release, and a wider pool of targeted diseases.

Vaccine developers are wrking on new drug delivery systems that offer improved immune responses, better stability, and a wider pool of targeted diseases.

Crucell and NIH Sign Ebola Vaccine Manufacturing Contract

HHS Awards $97-Million Vaccine Development Contract

"Stable Liquid" Technology Permits Heptavalent Vaccine Against Botulism

UK MHRA Okays Chiron Flu Vaccine Plant; FDA Approval Still to Come

CBER Draft Guidance for Spore-Formers and Plasmid Vaccines

MHRA to Reinspect Chiron Flu Vaccine Plant

Engineered Oilbodies Produce Vaccines and Adjuvants

Engineered Oilbodies Produce Vaccines and Adjuvants

Progress in developing AIDS vaccines is focussing attention on the challenges involved in producing millions of doses for developing nations.

New Bill Could Waive Vaccine Maker Liability

H5S1 Flu Vaccine Proven Safe